Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Emerging Mutations of SARS-COV-2 in Kenya

Version 1 : Received: 9 May 2024 / Approved: 10 May 2024 / Online: 10 May 2024 (11:30:40 CEST)

How to cite: Mbogori, E.; Thiongo, K.; Deng, H. Y.; Gikunyu, C.; Cheriro, W.; Musyoki, S.; Biegon, R.; Matoke-Muhia, D.; Patel, K.; Liang, B.; Songok, E. Emerging Mutations of SARS-COV-2 in Kenya. Preprints 2024, 2024050647. https://doi.org/10.20944/preprints202405.0647.v1 Mbogori, E.; Thiongo, K.; Deng, H. Y.; Gikunyu, C.; Cheriro, W.; Musyoki, S.; Biegon, R.; Matoke-Muhia, D.; Patel, K.; Liang, B.; Songok, E. Emerging Mutations of SARS-COV-2 in Kenya. Preprints 2024, 2024050647. https://doi.org/10.20944/preprints202405.0647.v1

Abstract

Background: The rise of new SARS-CoV-2 mutations brought challenges and progress in the global fight against COVID-19. Mutations in spike and accessory genes affect transmission, vaccine efficacy, treatments, testing, and public health strategies. Monitoring emerging variants is crucial to halt virus spread. Methods: 44 nasopharyngeal/oropharyngeal swabs from Kenyan patients were sequenced with the Illumina platform. Galaxy's bioinformatic tools were used for genomic analysis. SARS-CoV-2 genome classification was done using PANGOLIN and mutation annotation with the COVID-19 Annotator tool. Results: The study showed 5 clades to be circulating in the region. 38(86%) were BA.1.1; 2(5%) were BA.1.1.1; 1(2%) was BA.1; 1(2%) was BA.1.14 and 2(5%) were AY.46. These clades had a cumulative of 173 mutations among them with 50 novel mutations. Forty-eight of these novel mutations occurred in a low frequency of 2.3% of the sequences tested while the other two, S:R214R, and NSP2:A555A, were for 43.2% and 18.2% of the cases respectively. Conclusions: The high-frequency novel mutations were synonymous mutations, a phenomenon that was previously viewed as phenotypically silent but recent studies indicate they can affect viral fitness with potential functional associations. These findings add to the understanding of the SARS-CoV-2 virus future evolutionary and immunological dynamics in the region

Keywords

SARS-CoV-2; COVID-19; Spike protein; Epistasis; Reverse transcription; Pathogenesis; Vaccine efficacy; Complementary DNA; Reverse transcription-polymerase chain reaction

Subject

Biology and Life Sciences, Virology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.